Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Evaluating candidate principal surrogate endpoints.

Gilbert PB, Hudgens MG.

Biometrics. 2008 Dec;64(4):1146-54. doi: 10.1111/j.1541-0420.2008.01014.x. Epub 2008 Mar 24.

3.

Statistical evaluation of surrogate endpoints with examples from cancer clinical trials.

Buyse M, Molenberghs G, Paoletti X, Oba K, Alonso A, Van der Elst W, Burzykowski T.

Biom J. 2016 Jan;58(1):104-32. doi: 10.1002/bimj.201400049. Epub 2015 Feb 12. Review.

PMID:
25682941
5.

Statistical evaluation of biomarkers as surrogate endpoints: a literature review.

Weir CJ, Walley RJ.

Stat Med. 2006 Jan 30;25(2):183-203. Review.

PMID:
16252272
6.

Methodological issues in the use of composite endpoints in clinical trials: examples from the HIV field.

Wittkop L, Smith C, Fox Z, Sabin C, Richert L, Aboulker JP, Phillips A, Chêne G, Babiker A, Thiébaut R; NEAT-WP4.

Clin Trials. 2010 Feb;7(1):19-35. doi: 10.1177/1740774509356117. Review.

PMID:
20156955
7.

Biomarkers and surrogate endpoints in glaucoma clinical trials.

Medeiros FA.

Br J Ophthalmol. 2015 May;99(5):599-603. doi: 10.1136/bjophthalmol-2014-305550. Epub 2014 Jul 17. Review.

8.

[Immunological surrogate endpoints to evaluate vaccine efficacy].

Jin P, Li J, Zhou Y, Zhu F.

Zhonghua Yu Fang Yi Xue Za Zhi. 2015 Dec;49(12):1110-4. Review. Chinese.

PMID:
26887309
9.

Surrogate endpoints in randomized cardiovascular clinical trials.

Domanski M, Pocock S, Bernaud C, Borer J, Geller N, Revkin J, Zannad F.

Fundam Clin Pharmacol. 2011 Aug;25(4):411-3. doi: 10.1111/j.1472-8206.2010.00865.x. Epub 2010 Aug 4. Review.

PMID:
20698890
10.

Biomarkers and Surrogate Endpoints: Lessons Learned From Glaucoma.

Medeiros FA.

Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIO20-BIO26. doi: 10.1167/iovs.17-21987. Review.

11.

Definitions and validation criteria for biomarkers and surrogate endpoints: development and testing of a quantitative hierarchical levels of evidence schema.

Lassere MN, Johnson KR, Boers M, Tugwell P, Brooks P, Simon L, Strand V, Conaghan PG, Ostergaard M, Maksymowych WP, Landewe R, Bresnihan B, Tak PP, Wakefield R, Mease P, Bingham CO 3rd, Hughes M, Altman D, Buyse M, Galbraith S, Wells G.

J Rheumatol. 2007 Mar;34(3):607-15.

PMID:
17343307
12.

Biomarkers and correlative endpoints for immunotherapy trials.

Morse MA, Osada T, Hobeika A, Patel S, Lyerly HK.

Am Soc Clin Oncol Educ Book. 2013. doi: 10.1200/EdBook_AM.2013.33.e287. Review.

13.

Trends in Utilization of Surrogate Endpoints in Contemporary Cardiovascular Clinical Trials.

Patel RB, Vaduganathan M, Samman-Tahhan A, Kalogeropoulos AP, Georgiopoulou VV, Fonarow GC, Gheorghiade M, Butler J.

Am J Cardiol. 2016 Jun 1;117(11):1845-50. doi: 10.1016/j.amjcard.2016.03.021. Epub 2016 Mar 19. Review.

PMID:
27085935
14.

A unified framework for the evaluation of surrogate endpoints in mental-health clinical trials.

Molenberghs G, Burzykowski T, Alonso A, Assam P, Tilahun A, Buyse M.

Stat Methods Med Res. 2010 Jun;19(3):205-36. doi: 10.1177/0962280209105015. Epub 2009 Jul 16. Review.

PMID:
19608602
15.

Statistical challenges in the evaluation of surrogate endpoints in randomized trials.

Molenberghs G, Buyse M, Geys H, Renard D, Burzykowski T, Alonso A.

Control Clin Trials. 2002 Dec;23(6):607-25. Review.

PMID:
12505240
16.
17.
18.

Decade-Long Profile of Imaging Biomarker Use in Ophthalmic Clinical Trials.

Villani E, Massaro D, Scaramuzzi M, Hamrah P, Medeiros FA, Nucci P.

Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIO76-BIO81. doi: 10.1167/iovs.17-21790. Review.

PMID:
28525561
19.

Biomarkers and surrogate end points--the challenge of statistical validation.

Buyse M, Sargent DJ, Grothey A, Matheson A, de Gramont A.

Nat Rev Clin Oncol. 2010 Jun;7(6):309-17. doi: 10.1038/nrclinonc.2010.43. Epub 2010 Apr 6. Review.

PMID:
20368727
20.

Biomarkers and Surrogate Endpoints in Drug Development: A European Regulatory View.

Wickström K, Moseley J.

Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIO27-BIO33. doi: 10.1167/iovs.17-21778. Review.

PMID:
28475700

Supplemental Content

Support Center